Pharming Group (NASDAQ:PHAR) Earns Outperform Rating from Oppenheimer

Pharming Group (NASDAQ:PHAR) Earns Outperform Rating from Oppenheimer

Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Oppenheimer in a note issued to investors on Friday,Benzinga reports. They presently have a $41.00 target price on the stock, down from their prior target price of $42.00. Oppenheimer’s price objective points to a potential upside of 182.56% from the company’s previous close. Several other analysts have also recently weighed in on the sto…